16-16154899-G-T
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM1PM2PM5PP3_ModeratePP5_Moderate
The NM_001171.6(ABCC6):c.4015C>A(p.Arg1339Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000658 in 152,080 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1339L) has been classified as Uncertain significance.
Frequency
Consequence
NM_001171.6 missense
Scores
Clinical Significance
Conservation
Publications
- arterial calcification, generalized, of infancy, 2Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
- autosomal recessive inherited pseudoxanthoma elasticumInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Orphanet, Labcorp Genetics (formerly Invitae), G2P
- arterial calcification of infancyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001171.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ABCC6 | NM_001171.6 | MANE Select | c.4015C>A | p.Arg1339Ser | missense | Exon 28 of 31 | NP_001162.5 | ||
| ABCC6 | NM_001440309.1 | c.3982C>A | p.Arg1328Ser | missense | Exon 28 of 31 | NP_001427238.1 | |||
| ABCC6 | NM_001440310.1 | c.3847C>A | p.Arg1283Ser | missense | Exon 27 of 30 | NP_001427239.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ABCC6 | ENST00000205557.12 | TSL:1 MANE Select | c.4015C>A | p.Arg1339Ser | missense | Exon 28 of 31 | ENSP00000205557.7 | ||
| ABCC6 | ENST00000456970.6 | TSL:2 | n.*1024C>A | non_coding_transcript_exon | Exon 26 of 29 | ENSP00000405002.2 | |||
| ABCC6 | ENST00000576204.6 | TSL:5 | n.878C>A | non_coding_transcript_exon | Exon 1 of 2 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152080Hom.: 0 Cov.: 31 show subpopulations
GnomAD4 exome Cov.: 32
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152080Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74290 show subpopulations
ClinVar
Submissions by phenotype
not provided Pathogenic:1
This sequence change replaces arginine, which is basic and polar, with serine, which is neutral and polar, at codon 1339 of the ABCC6 protein (p.Arg1339Ser). This variant is present in population databases (rs28939702, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with ABCC6-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ABCC6 protein function. This variant disrupts the p.Arg1339 amino acid residue in ABCC6. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 10954200, 12384774, 24352041, 27994049). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at